MINSTNCT07928752
Effects of Adjunctive Melatonin Gel in Type II Diabetics With Stage III-IV Periodontitis
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Clinical Attachment Level (CAL)
Timeframe: from enrollment to 4 weeks then to the end of the study at 8 weeks
Secondary (7)
Probing Pocket Depth (PPD)
Full mouth plaque score (FMPS)
Full mouth bleeding score (FMBS)
GCF Galectin-3
GCF Interleukin 1
Show 2 moreShow less
Serum glycemic level
Patient satisfaction
Arms and interventions
MINST + Melatonin GelExperimental
Participants will receive minimally invasive non-surgical periodontal therapy (MINST), followed by adjunctive subgingival application of 5% melatonin gel into selected periodontal pockets using a syringe equipped with a suitable cannula, once weekly for four consecutive weeks.
MINST AloneActive comparator
Participants will receive minimally invasive non-surgical periodontal therapy (MINST) alone, without adjunctive melatonin gel.
Procedures: Minimally Invasive Non-Surgical Periodontal Therapy (MINST), 5% Melatonin Gel
Sites
1 site in 1 country
- Badr University in CairoNew Cairo, Cairo Governorate, Egypt